» Articles » PMID: 37360014

Potential Herb‒drug Interactions Between Anti-COVID-19 Drugs and Traditional Chinese Medicine

Overview
Publisher Elsevier
Specialty Pharmacology
Date 2023 Jun 26
PMID 37360014
Authors
Affiliations
Soon will be listed here.
Abstract

Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has spread worldwide. Effective treatments against COVID-19 remain urgently in need although vaccination significantly reduces the incidence, hospitalization, and mortality. At present, antiviral drugs including Nirmatrelvir/Ritonavir (Paxlovid), Remdesivir, and Molnupiravir have been authorized to treat COVID-19 and become more globally available. On the other hand, traditional Chinese medicine (TCM) has been used for the treatment of epidemic diseases for a long history. Currently, various TCM formulae against COVID-19 such as Qingfei Paidu decoction, Xuanfei Baidu granule, Huashi Baidu granule, Jinhua Qinggan granule, Lianhua Qingwen capsule, and Xuebijing injection have been widely used in clinical practice in China, which may cause potential herb-drug interactions (HDIs) in patients under treatment with antiviral drugs and affect the efficacy and safety of medicines. However, information on potential HDIs between the above anti-COVID-19 drugs and TCM formulae is lacking, and thus this work seeks to summarize and highlight potential HDIs between antiviral drugs and TCM formulae against COVID-19, and especially pharmacokinetic HDIs mediated by metabolizing enzymes and/or transporters. These well-characterized HDIs could provide useful information on clinical concomitant medicine use to maximize clinical outcomes and minimize adverse and toxic effects.

Citing Articles

Angiotensin-converting enzyme 2 and hepatic SARS-CoV-2 infection: Regulation, association, and therapeutic implications.

Luo Y, Huang A, Tang K World J Gastroenterol. 2025; 31(6):100864.

PMID: 39958440 PMC: 11752700. DOI: 10.3748/wjg.v31.i6.100864.


Modulation of Multispecific Transporters by Extract and Its Major Phytoconstituents.

Szilvasy N, Lajer P, Horvath A, Veres K, Hohmann J, Schelz Z Pharmaceutics. 2024; 16(11).

PMID: 39598486 PMC: 11597817. DOI: 10.3390/pharmaceutics16111363.


An integrated approach for studying exposure, metabolism, and disposition of traditional Chinese medicine using PATBS and MDRB tools: a case study of semen Armeniacae Amarum.

Zhang D, Zhang J, Chen S, Zhang H, Yang Y, Jiang S Chin Med. 2024; 19(1):158.

PMID: 39543720 PMC: 11566643. DOI: 10.1186/s13020-024-01031-8.


Screening for anti-influenza virus compounds from traditional Mongolian medicine by GFP-based reporter virus.

Nie M, Li X, Zhang S, Zeng D, Cai Y, Peng D Front Cell Infect Microbiol. 2024; 14:1431979.

PMID: 39071166 PMC: 11272615. DOI: 10.3389/fcimb.2024.1431979.


Survey of Potential Drug Interactions, Use of Non-Medical Health Products, and Immunization Status among Patients Receiving Targeted Therapies.

Rajj R, Schaadt N, Bezsila K, Balazs O, Jancso M, Auer M Pharmaceuticals (Basel). 2024; 17(7).

PMID: 39065792 PMC: 11279607. DOI: 10.3390/ph17070942.


References
1.
Efferth T . From ancient herb to modern drug: Artemisia annua and artemisinin for cancer therapy. Semin Cancer Biol. 2017; 46:65-83. DOI: 10.1016/j.semcancer.2017.02.009. View

2.
Tang J, Zhang J, Wu Y, Li Z . Effect of the water extract and ethanol extract from traditional Chinese medicines Angelica sinensis (Oliv.) Diels, Ligusticum chuanxiong Hort. and Rheum palmatum L. on rat liver cytochrome P450 activity. Phytother Res. 2006; 20(12):1046-51. DOI: 10.1002/ptr.1974. View

3.
Lin N, Liu B, Zhang J, Long Y, Dong G, Jin H . Acute toxicity, 28-day repeated-dose toxicity and toxicokinetic study of timosaponin BII in rats. Regul Toxicol Pharmacol. 2017; 90:244-257. DOI: 10.1016/j.yrtph.2017.09.021. View

4.
Ji S, Park S, Bae S, Seo H, Kim S, Lee G . Comprehensive Investigation of Stereoselective Food Drug Interaction Potential of Resveratrol on Nine P450 and Six UGT Isoforms in Human Liver Microsomes. Pharmaceutics. 2021; 13(9). PMC: 8470274. DOI: 10.3390/pharmaceutics13091419. View

5.
Yang A, Zhang L, Zhi D, Liu W, Gao X, He X . Identification and analysis of the reactive metabolites related to the hepatotoxicity of safrole. Xenobiotica. 2017; 48(11):1164-1172. DOI: 10.1080/00498254.2017.1399227. View